T. Ginap et H. Kilbinger, NK1-RECEPTOR AND NH3-RECEPTOR MEDIATED INHIBITION OF 5-HYDROXYTRYPTAMINE RELEASE FROM THE VASCULARLY PERFUSED SMALL-INTESTINE OF THE GUINEA-GIG, Naunyn-Schmiedeberg's archives of pharmacology, 356(5), 1997, pp. 689-693
The effects of tachykinins on the spontaneous release of 5-hydroxytryp
tamine (5-HT) from the enterochromaffin cells into the portal circulat
ion was investigated in vitro using the vascularly perfused isolated g
uinea-pig small intestine. 5-HT was determined by HPLC with electroche
mical detection. Test substances were applied intraarterially. Substan
ce P (SP) caused a concentration-dependent decrease in 5-HT outflow wi
th an EC50 of 50 pmol/l. Similarly, the selective NK1 receptor agonist
SP methyl ester (1 nmol/l) significantly inhibited 5-HT outflow (to 5
1+/-3%). When tetrodotoxin (1 mu mol/l) was added to the arterial perf
usion medium, the inhibition by SP of 5-HT outflow was not affected. T
he selective NK1 receptor antagonist CP 99994 S,3S)-3-(2-methoxybenzyl
amino)-2-phenylpiperidine] (0.1 mu mol/l) prevented the inhibitory eff
ect of SP (0.1 mu mol/l). Neither GR 94800 (PhCO-Ala-Ala-DTrp-Phe-DPro
-Pro-NleNH(2)) (0.1 mu mol/l) nor SR 142801 propyl)-4-phenylpiperidin-
4-yl)-N-methylacetamide] (10 nmol/l), which are selective NK2 and NK3
receptor antagonists, changed the SP-mediated inhibition. The selektiv
e NK3 receptor agonist senktide (10 nmol/l) also decreased the 5-HT ou
tflow (to 57+/-5%). This inhibition was prevented by SR 142801 (10 nmo
l/l) and by tetrodotoxin. CP 99994 (0.1 mu mol/l) significantly antago
nized the senktide-mediated inhibition of 5-HT outflow. The outflow of
5-HT was unaffected when CP 99994, GR 94800 or SR 142801 alone were a
dded to the perfusion medium. It is concluded that the release of 5-HT
from enterochromaffin cells is directly inhibited by NK1 receptors, a
nd indirectly by neuronal NK3 receptors whose stimulation leads to the
release of SP.